Trump's Controversial Health Agency Picks Stir Debate
TL;DR Summary
Martin Makary, President-elect Trump's nominee for FDA commissioner, is an executive at Sesame, a telehealth company involved in prescribing compounded weight-loss drugs. His confirmation could influence FDA policies affecting the compounding of cheaper drug versions amid ongoing disputes between branded drug manufacturers and compounding pharmacies. The FDA's role in determining drug shortages, which allows pharmacies to compound drugs, is central to this issue.
- Trump’s pick to run FDA is top exec of company that provides compounded weight-loss drugs STAT
- Trump Chooses New York Doctor to Be Next U.S. Surgeon General The New York Times
- What to know about Trump's picks for CDC, FDA and surgeon general NPR
- Trump names a Fox News personality, a COVID mandate critic and an anti-vaccine doctor to key public health roles PBS NewsHour
- A look at how some of Trump's picks to lead health agencies could help carry out Kennedy's overhaul The Associated Press
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
1 min
vs 2 min read
Condensed
80%
309 → 63 words
Want the full story? Read the original article
Read on STAT